Global Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Report ID: BMRC 49 | Number of pages: 200 | Publish Date: May 2019 | Publisher: BMRC | Category: Chemicals and Materials
Global Sunitinib Malate Market: 2018-2024
Brandessence Market Research is working on a new report title“Global Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024?. Rising occurrence of pancreatic cancer, the convenience of a less drug therapeutic selections for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the early phases of pancreatic cancer are some key drivers for Global Sunitinib Malate Market.

Scope of Global Sunitinib Malate Market Reports –

 Sunitinib Malate is the small molecule, orally bioavailable malate salt of an indolinone-based multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the Food and Drug Administration (FDA) for the treatment of Carcinoma. Sunitinib Malate is having molecular formula C22H27FN4O2 so molecular weight is 398.482 g/mol. The possible antineoplastic activity of Sunitinib has managed to it being observed as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treatment of Pancreatic Neuroendocrine Tumors, Kidney Cancer and Gastrointestinal Stromal Tumor (GIST).

Mechanism of action of Sunitinib Malate is it prevents cellular signaling by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib Malate also inhibits CD117 (c-KIT), the receptor tyrosine kinase that drives the many gastrointestinal stromal cell tumors. The side effects of Sunitinib Malate are Diarrhea, Heartburn, Hypertension, fatigue, Nausea and Vomiting, skin discoloration, cough, upset stomach, hair loss, fever, abdominal pain, shortness of breath, watery eyes, numbness or tingling of the arms or legs and swelling around the eyes.

Global Sunitinib Malate Market has been segmented on the basis of Application and Geography. On the basis of Application Global Sunitinib Malate Market is classified into Pancreatic Neuroendocrine Tumors, Advanced Kidney Cancer, Gastrointestinal stromal tumor (GIST) and others.

The regions covered in Global Sunitinib Malate Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Sunitinib Malate Market Reports –

Global Sunitinib Malate Market reports cover prominent players like Pfizer, Topcare pharmaceutical Co. Ltd, Nanjing First Pharmaceutical Co. Ltd., J&K Scientific, Target Molecule Corp., Medichem, Biotechnica Pharma Global, Beijing Lunarsun Pharmaceutical Co. LTD, Brawn Laboratories Ltd INDIA, Hetero Drugs Ltd INDIA, Hikma Pharmaceutical plc, Jeil Pharmaceutical Co. Ltd, Natco Pharma LTD, Reliance Life Sciences Pvt. Ltd, Shilpa Medicare Ltd INDIA, Sichuan Xieli Pharmaceutical Co LTD, Synthland Ltd and Teva Pharmaceutical Industries Ltd. 

 Global Sunitinib Malate Market Dynamics –

Rising incidence of pancreatic neuroendocrine tumors, pancreatic cancer is a main driver for the Global Sunitinib Malate Market. Likewise, accessibility of an inadequate number of drug therapeutics for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the initial phases of pancreatic cancer is increasing the demand of Sunitinib Malate in the treatment of pancreatic cancer. Conversely high cost of Sutent is one of the key restraints of the Global Sunitinib Malate Market growth. For 28 capsules of Sutent 37.5mg average cash price is $17,968.99. Some side effects of Sutent such as Hepatotoxicity and Adverse cardiovascular events like heart failure, myocardial infarction and coronary artery bypass grafting have also been reported during clinical trials, which could discourage adoption of the drug. Increase in awareness about the disease and technological expansions are likely to raise the Global Sunitinib Malate Market. Also Rising Prevalence of Cancer, Increase in Pharmaceutical R&D Spending, Rising Healthcare Expenditure and Rising Asian Population will boost the Global Sunitinib Malate Market. Systematic Drugs under Pipeline, Rising Scope for Cancer Therapy and increasing awareness towards Carcinoma are some opportunities in the forecast period for the Global Sunitinib Malate Market.

Global Sunitinib Malate Market Regional Analysis –

North America holds the largest share of Global Sunitinib Malate Market amongst others. It is mainly driven by quickly increasing incidence of pancreatic cancer.  Moreover the incomes of customers and health insurance cover for life-threatening diseases in U.S. are very high which raises the affordability of cancer treatment. In recent years, US Food and Drug Administration (USFDA) has taken initiatives to support the progress of cancer drugs market by providing pre-market approval to the drugs, which are in the clinical phase therefore hastening the clinical development. Asia-Pacific is likely to grow vastly in the future due to some factors such as high occurrence of cancer, rising awareness regarding cure and treatment of cancer and increasing partnership between public and private areas to offer innovative cancer therapy in the region. The incidence of various types of cancer is much more in developing countries which concentrate these regions as favorable locations to conduct clinical trials. Furthermore the cost of clinical research is less in these regions due to the accessibility of a vast population base and favorable government policies contributing to the cancer drugs market growth in the developing countries.

Key Benefits for Global Sunitinib Malate Market Reports –

Global Sunitinib Malate Market report covers in depth historical and forecast analysis.
Global Sunitinib Malate Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Sunitinib Malate Market report helps to identify opportunities in market place.
Global Sunitinib Malate Market report covers extensive analysis of emerging trends and competitive landscape.
Global Sunitinib Malate Market Segmentation –

Global Sunitinib Malate Market: By Application Analysis

Pancreatic Neuroendocrine Tumors
Advanced Kidney Cancer
Gastrointestinal stromal tumor (GIST)
Other
Global Sunitinib Malate Market: By Regional & Country Analysis

North America
U.S.
Mexico
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
The Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Table of Content

Chapter – Report Methodology
Research Process
Primary Research
Secondary Research
Market Size Estimates
Data Triangulation
Forecast Model
USP’s of Report
Report Description
Chapter – Global Sunitinib Malate Market Overview: Qualitative Analysis
Market Introduction
Executive Summary
Global Sunitinib Malate Market Classification
Market Drivers
Market Restraints
Market Opportunity
Global Sunitinib Malate Market: Trends
Porter’s Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Consumers
Threat of New Entrants
Threat of Substitute Product and Services
Competitive Rivalry within the Industry
Market Attractiveness Analysis
Market Attractiveness Analysis by Segmentation
Market Attractiveness Analysis by Region
Chapter – Global Sunitinib Malate Market Overview: Quantitative Analysis
Global Sunitinib Malate Market Production (Kg), Market Share (%) and Growth Rate (%), 2014- 2024
Global Sunitinib Malate Market Consumption (Kg), Market Share ( %) and Growth Rate, 2014- 2024
Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
Chapter – Global Sunitinib Malate Market : by Application
Chapter – Global Sunitinib Malate Market : by Manufacturer
Global Sunitinib Malate Market (USD Million), by Manufacturer, 2014 – 2024
Global Sunitinib Malate Market Production (Kg), by Manufacturer, 2014 – 2024
Global Sunitinib Malate Market Consumption (Kg), Manufacturer, 2014 – 2024
Global Sunitinib Malate Market Share (%), by Manufacturer, 2017
Global Sunitinib Malate Market Price (USD/Unit), by Manufacturer, 2014 – 2024
Global Sunitinib Malate Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
Merger & Acquisition
Collaborations and Partnership
New Product Launch
Chapter – Global Sunitinib Malate Market: Regional Analysis
North America
North America Global Sunitinib Malate Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
North America Global Sunitinib Malate Market Revenue (USD Million) By Country, 2014 – 2024.
North America Global Sunitinib Malate Market Revenue Market Share (%) By Country, 2014 – 2024.
North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
North America Global Sunitinib Malate Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
Europe
Asia Pacific
Latin America
Middle East & Africa
Chapter – Company Profiles
Pfizer
Overview
Financials
Product portfolio
Global Sunitinib Malate Market Revenue (USD Million), Production     (Kg), Consumption (Kg) and Market Share (%), 2014 – 2017
Global Sunitinib Malate Market Share (%), 2014 – 2017
Business strategy
Recent developments
Topcare pharmaceutical Co. Ltd
Nanjing First Pharmaceutical Co. Ltd.
J&K Scientific
Target Molecule Corp.
Medichem
Biotechnica Pharma Global
Beijing Lunarsun Pharmaceutical Co. LTD
Brawn Laboratories Ltd INDIA
Hetero Drugs Ltd INDIA
Hikma Pharmaceutical plc
Jeil Pharmaceutical Co. Ltd
Natco Pharma LTD
Reliance Life Sciences Pvt. Ltd
Shilpa Medicare Ltd INDIA
Sichuan Xieli Pharmaceutical Co LTD
Synthland Ltd
Teva Pharmaceutical Industries Ltd.
Others
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.